Skip to content

Inventories at other companies

3M logo
3MMMM
$3.69B-4.6%
Danaher logo
DanaherDHR
$2.61B+3.0%
STERIS logo
STERISSTE
$631.8M+8.7%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$359.72M+24.0%
Fortive logo
FortiveFTV
$305.5M-46.2%
Revvity logo
RevvityRVTY
$387.51M+1.6%

Segments

By segment

See full
Clinical Genomics$8.32M-14.9%
Biopharmaceutical Development$6.51M+32.0%

Other financials

Income statement

See full
Revenue$63.7M+2.6%
Gross profit$31.2M-0.5%
Operating income-$664.0K+85.5%
Net income$3.6M+317%
EPS (diluted)-$0.10+63.0%

Balance sheet

See full
Cash & equivalents$26.9M-1.4%
Total debt$78.7M-53.1%
Total equity$186.2M+16.5%
Total assets$427.7M-1.3%

Cash flow

See full
Operating cash flow$14.0M+10.2%
CapEx$417.0K-44.9%
Free cash flow$13.5M+13.7%

Valuation

See full
Market cap$542.27M+3.7%
Enterprise value$594.05M-10.4%
P/S2.2×0.0×

Profitability

See full
Gross margin56.8%
Operating margin2.3%
Net margin1.5%+0.8pp
FCF margin15.9%-1.8pp

Returns & leverage

See full
Return on equity2.2%+1.1pp
Debt / equity0.4×-0.6×
Current ratio1.7×+1.1×

Where this comes from

Reported directly by Mesa Laboratories in its filing.

Tagged under the XBRL concept us-gaap:InventoryNet.

The official record: Mesa Laboratories’s 10-K, filed June 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mesa Laboratories's inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mesa Laboratories's inventories?
Mesa Laboratories (MLAB) reported inventories of $26.37M in Q1 2026.
How has Mesa Laboratories's inventories changed year-over-year?
Mesa Laboratories's inventories increased by 4.0% year-over-year, from $25.37M to $26.37M.
What is the long-term trend for Mesa Laboratories's inventories?
Over 5 years (2021 to 2026), Mesa Laboratories's inventories has grown at a 18.7% compound annual growth rate (CAGR), from $11.18M to $26.37M.
What does inventories mean?
Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.